Table 4 MRI outcomes.

From: Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [11C]PIB PET study

 

Mean (SD)

Subjects with alcohol-use disorder (n = 19)

Healthy controls (n = 20)

p-Value

Cortical thickness (mm)

 AD-signature composite

2.6 (0.2)

2.8 (0.1)

0.0003

 Entorhinal

3.5 (0.4)

3.7 (0.4)

0.12

 Inferior temporal

2.6 (0.2)

2.8 (0.1)

0.01

 Middle temporal

2.6 (0.2)

2.8 (0.1)

0.0001

 Fusiform

2.6 (0.2)

2.7 (0.1)

0.002

 Prefrontal

2.3 (0.1)

2.4 (0.1)

0.01

 Parietal

2.0 (0.1)

2.2 (0.1)

0.0001

 Occipital

1.9 (0.1)

2.0 (0.1)

0.003

GM volumesa (unitless)

 Hippocampus

26.4 (3.1)

29.3 (2.2)

0.002

 Amygdala

10.6 (1.3)

11.5 (0.9)

0.02

 Thalamus

43.0 (4.5)

46.2 (4.3)

0.03

 Caudate

22.3 (2.5)

22.2 (2.2)

0.83

 Putamen

33.7 (4.0)

36.1 (3.6)

0.05

 Nucleus accumbens

4.0 (0.7)

4.4 (0.5)

0.03

 Cerebellar cortex

296.6 (30.3)

321.4 (31.5)

0.02

  1. aNormalized to ICV. Raw volumes in Supplemental Table 6.